Literature DB >> 12917256

Increased plasma cell frequency and accumulation of abnormal syndecan-1plus T-cells in Igmu-deficient/lpr mice.

Jane Seagal1, Nira Leider, Gizi Wildbaum, Nathan Karin, Doron Melamed.   

Abstract

The expression of muH chain is an important checkpoint in B cell development. In mice deficient for IgM transmembrane tail exons (muMT mice) B cell development is blocked at the pro-B stage. However, we showed that Fas-deficient muMT mice (muMT/lpr) develop a very small population of isotype-switched B cells and produce high titers of self-reactive serum antibodies. In addition, muMT/lpr mice develop severe lymphoproliferation and both pathologic processes occur at young ages. This may suggest that lack of Fas-Fas ligand signaling exacerbates murine lupus in B cell lymphopenic mice. To test this we analyzed antibody and plasma cell formation, and accumulation of abnormal T cells in muMT/lpr mice. Our results show that the muMT/lpr mouse is particularly permissive for the development and accumulation of antibody-producing cells, thereby explaining the high titers of serum antibodies in these mice. In addition, we found that accumulating cells in spleen and lymph nodes of muMT/lpr mice are alphabeta T cells expressing the abnormal B220+/CD3+ surface markers, a phenotype also described for other Fas-deficient mouse models. Strikingly, we found that accumulating cells in muMT/lpr mice express the membrane proteoglycan syndecan-1, a known plasma cell marker. Development of these cells is blocked in mice deficient for TCRbeta and TCRdelta. We also found that both antibody production and lymphoproliferation in muMT/lpr mice are Th1 regulated. Our results, therefore, suggest that in the muMT/lpr mouse model a small population of isotype-switched B cells is sufficient for the initiation and propagation of Th1-regulated murine lupus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12917256     DOI: 10.1093/intimm/dxg107

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  9 in total

1.  Syndecan-1 and E-cadherin expression in differentiated type of early gastric cancer.

Authors:  Mei-Fang Huang; You-Qing Zhu; Zhi-Fen Chen; Jun Xiao; Xin Huang; Yong-Yan Xiong; Gui-Fang Yang
Journal:  World J Gastroenterol       Date:  2005-05-21       Impact factor: 5.742

Review 2.  Lymph node vascular-stromal growth and function as a potential target for controlling immunity.

Authors:  Fairouz Benahmed; Scott Ely; Theresa T Lu
Journal:  Clin Immunol       Date:  2012-05-11       Impact factor: 3.969

Review 3.  TCRzeta mRNA splice variant forms observed in the peripheral blood T cells from systemic lupus erythematosus patients.

Authors:  Kensei Tsuzaka; Kyoko Nozaki; Chika Kumazawa; Kiyono Shiraishi; Yumiko Setoyama; Keiko Yoshimoto; Tohru Abe; Tsutomus Takeuchi
Journal:  Springer Semin Immunopathol       Date:  2006-09-05

4.  Contribution of alphabeta and gammadelta T cells to the generation of primary immunoglobulin G-driven autoimmune response in immunoglobulin- mu-deficient/lpr mice.

Authors:  Jane Seagal; Doron Melamed
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

5.  LangChuangHeJi decoction ameliorates lupus via preventing accumulation of CD138+ T cells in MRL/lpr mice.

Authors:  Tianhong Xie; Xin Liu; Huiqiang Liu; Xuyang Han; Jingxia Zhao; Dongmei Zhou; Yan Wang; Hongkai Zhang; Ping Wang; Ping Li
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

6.  Normalization of the lymph node T cell stromal microenvironment in lpr/lpr mice is associated with SU5416-induced reduction in autoantibodies.

Authors:  Susan Chyou; Sha Tian; Eric H Ekland; Theresa T Lu
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240

7.  Glucocorticoid prevents CD138 expression in T cells of autoimmune MRL/lpr mice.

Authors:  Tianhong Xie; Huiqiang Liu; Ping Li
Journal:  Mol Med Rep       Date:  2022-05-06       Impact factor: 3.423

8.  Depletion of B cells rejuvenates the peripheral B-cell compartment but is insufficient to restore immune competence in aging.

Authors:  Irit Avivi; Simona Zisman-Rozen; Shulamit Naor; Isabelle Dai; David Benhamou; Gitit Shahaf; Hilla Tabibian-Keissar; Noemie Rosenthal; Aviya Rakovsky; Ammuri Hanna; Arik Shechter; Eli Peled; Noam Benyamini; Ekaterina Dmitrukha; Iris Barshack; Ramit Mehr; Doron Melamed
Journal:  Aging Cell       Date:  2019-05-06       Impact factor: 9.304

9.  Disease Stage-Specific Pathogenicity of CD138 (Syndecan 1)-Expressing T Cells in Systemic Lupus Erythematosus.

Authors:  Lunhua Liu; Kazuyo Takeda; Mustafa Akkoyunlu
Journal:  Front Immunol       Date:  2020-07-28       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.